An Analysis of Telehealth in the Pharmaceutical Industry


Regular Price: USD 1,500.00

Special Price USD 1,050.00

30% OFF

* Required Fields

Regular Price: USD 1,500.00

Special Price USD 1,050.00


Be the first to review this product

This market insight provides an overview of the telehealth and pharmaceutical industry in North America. This piece defines the market space, assesses how telehealth in pharma fits into the Frost & Sullivan telehealth matrix, and discusses the market challenges. Also provided are market briefs on different aspects of pharma telehealth programs, complete with company examples and market landscape information for novel information exchange, mobile phone apps, smart pills, and medication management systems. Three key analyst predictions about telehealth in the pharmaceutical and biotechnology industry are also presented and discussed.

Table of Contents

An Analysis of Telehealth in the Pharmaceutical IndustryThe Numerous and Often Misunderstood Opportunities Telehealth Presents to PharmaIntroductionDefining a Complex MarketTelehealth Matrix and Spectrum - Pharma and Telehealth, Buyer SpectrumIndustry Challenges for Telehealth and PharmaMarket Briefs: Novel Information Exchange, Mobile Apps, Smart Pills, Medication Management SystemsThree Big PredictionsAbout Frost & Sullivan

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.